ATS GUIDELINES Bundle

Drug-Resistant Tuberculosis

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1206585

Contents of this Issue

Navigation

Page 12 of 15

13 Children Reduced Renal Function a ≥ 35 kg : adult dose ≥ 6 years and 20–34 kg : 50 mg 2× a day >3–5 years and 10–20 kg : 25 mg 2× a day Lower age/weight: studies ongoing Mild-moderate renal insufficiency – no change. Severe insufficiency – limited data, use with caution 20–25 mg/kg/day 3×/wk 30–40 mg/kg/day 3×/wk 15–20 mg/kg total (divided 1–2 times daily) No change needed 15–20 mg/kg total (divided 1–2 times daily) No change needed (imipenem component) 15–25 mg/kg/dose 4× a day May reduce frequency 20–40 mg/kg/dose 3× a day May reduce frequency 25 mg/kg/dose of amoxicillin component 3 ×/day May reduce frequency to match carbapenem 200–300 mg/kg/day in two divided doses j No change needed 15–20 mg/kg/day No change needed g Ethionamide can be given at bedtime or with a meal to reduce nausea. Experienced clinicians suggest starting with 250 mg once daily and gradually increasing the dose over 1 week. Serum concentrations may be useful in determining the appropriate dose. Few patients tolerate 500 mg twice daily. h Studies are ongoing evaluating meropenem at higher doses (ClinicalTrials.gov identifiers: NCT03174184 and NCT02349841). i Some experts prescribe p-aminosalicylic acid at 6 g, and up to12 g, administered once daily. j For children, some experts prescribe p-aminosalicylic acid at 200 mg/kg administered once daily. k Isoniazid is tested at two concentrations. Some experts use these results (or resistance conferred through mutations in inhA) to select a higher dose when it tests resistant at the lower concentration and susceptible at the higher concentration. e higher dose may achieve in vivo concentrations sufficiently high to overcome low-level resistance.

Articles in this issue

Links on this page

view archives of ATS GUIDELINES Bundle - Drug-Resistant Tuberculosis